SciVision Biotech Inc.
Research SciVision Biotech Inc. (1786.TW) on Bullrun: market cap TWD 2.98B, P/E 17.4, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1786.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 2.98B
- P/E17.4
- Dividend yield4.8%
- Financial periodQ2 2026
- RevenueTWD 211.03M
- Net incomeTWD 34.64M
- Free cash flowTWD 63.33M
- Gross margin65.9%
Valuation Snapshot
latest market cap is TWD 2.98B; P/E is 17.4; dividend yield is 4.8%.
Peer valuation comparison
Latest P/E is 17.35x versus a Healthcare sector median of 21.8x (20.4% below).
Latest dividend yield is 4.79% versus a Healthcare sector median of 2.41% (98.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.98B | 17.4 | 4.7% | 1.91 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.91 TWD, yield 4.8%.
About SciVision Biotech Inc.
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SciVision Biotech Inc.'s market cap?
SciVision Biotech Inc.'s market capitalization is TWD 2.98B.
What is SciVision Biotech Inc.'s P/E ratio?
SciVision Biotech Inc.'s price-to-earnings (P/E) ratio is 17.4.
Does SciVision Biotech Inc. pay a dividend?
SciVision Biotech Inc. has a dividend yield of 4.8%.
What does SciVision Biotech Inc. do?
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.